GENE ONLINE|News &
Opinion
Blog

2026-01-23|

Residual Cardiovascular Risk Persists in Coronary Artery Disease Despite Advances in Treatment

by GOAI
Share To

Recent findings highlight the ongoing issue of residual cardiovascular risk in patients with coronary artery disease (CAD), despite significant progress in cardiovascular health advancements. Atherosclerosis, a condition marked by the accumulation of fatty deposits in coronary arteries, remains the leading cause of death worldwide. This persistent risk continues to pose challenges for medical professionals and researchers working to improve outcomes for individuals with CAD.

Atherosclerosis contributes significantly to the development of CAD, which can lead to severe complications such as heart attacks and strokes. While modern treatments and preventive measures have reduced mortality rates associated with cardiovascular diseases, many patients still face substantial risks even after receiving optimal care. The global prevalence of atherosclerosis underscores its impact on public health, emphasizing the need for continued research into mitigating residual risks and improving long-term management strategies for affected individuals.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 23, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
NETSTREIT Corp Announces Upsized Forward Sale of 11 Million Shares at $18.90 Each
2026-02-11
Copart to Release Q2 Fiscal Year 2026 Financial Results on February 12 at 3:05 AM GMT
2026-02-11
BioRestorative Therapies Announces $5 Million Public Offering to Fund Operations
2026-02-11
Shriners Children’s Launches Multi-Center Study on Fractional CO2 Laser Technology for Pediatric Burn Care
2026-02-11
Rising Lung Cancer Cases Among Non-Smokers Linked to Genetic and Environmental Factors
2026-02-11
Path Planning Transformer Introduced to Enhance Multi-Robot Navigation in Complex Environments
2026-02-11
Amrize Corporation Appoints Three New Directors Following Departure of James Carter and Linda Nguyen
2026-02-11
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
DCAT Week
New York, USA
Scroll to Top